Terbufibrol

CAS: 56488-59-6

Ref. 3D-GCA48859

Produktinformation

• Name: Terbufibrol
• Synonyme: Terbufibrol [INN], 4'-(3-(4'-t-Butylphenoxy)-2-hydroxypropoxy)benzoic acid, 4-(3-(4-(1,1-Dimethylethyl)phenoxy)-2-hydroxypropoxy)benzoic acid, Brn 2949416, K-11,267, Terbufibrolum, Terbufibrolum [INN-Latin], Unii-W41Z308Ia3, p-(3-(p-tert-Butylphenoxy)-2-hydroxypropoxy)benzoic acid, Benzoic acid, 4-(3-(4-(1,1-dimethylethyl)phenoxy)-2-hydroxypropoxy)-, Benzoic acid, p-(3-(p-tert-butylphenoxy)-2-hydroxypropoxy)-, 4-[3-(4-Tert-Butylphenoxy)-2-Hydroxypropoxy]Benzoic Acid

Beschreibung

Terbufibrol is a protein synthesis inhibitor that belongs to the group of dietary, diagnostic, and pharmacologic agents. It is used in animals for the treatment of atherosclerosis and other conditions. Terbufibrol inhibits cholesterol synthesis by inhibiting mevalonate production. It also has been shown to inhibit cholesterol synthesis in human serum through inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA), which is an enzyme that catalyzes the conversion of HMG-CoA to mevalonate. Terbufibrol has also been shown to be a plasma marker enzyme for atherogenesis.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 344.4 g/mol
• Formel: C₂₀H₂₄O₅
• Reinheit: Min. 95%